首页|中医药辨证治疗亚实性肺结节的实用性随机对照研究

中医药辨证治疗亚实性肺结节的实用性随机对照研究

扫码查看
原文链接
  • 万方数据
  • 维普
目的 探讨中医药在亚实性肺结节(SSN)中的治疗效果.方法 纳入SSN患者254例,分为中药组102例与随访组152例,随访组根据指南推荐定期复查,中药组给予中药辨证治疗24周,对比两组患者治疗前后SSN直径、数目、中医症状积分并评价总体疗效,记录不良反应发生情况及安全性指标.结果 中药组治疗有效率(16.7%)显著高于随访组(2.6%)(P<0.01).与本组治疗前相比,中药组SSN直径、数目无显著变化,乏力、小便黄赤症状积分及中医症状总分均显著降低(P<0.05);随访组SSN直径显著增大(P<0.01)、数目显著增多(P<0.01).组间对比显示:治疗后随访组SSN直径增大程度显著高于中药组(P<0.05),乏力、情志抑郁、小便黄赤症状积分及中医症状总分显著高于中药组(P<0.05或P<0.01).结论 中医药治疗SSN临床疗效明确,能降低SSN恶性风险,改善SSN患者临床症状且安全可行,可进一步研究和应用.
A Practical Randomized Controlled Study on Effectiveness of TCM Syndrome Differentiation Treatment for Subsolid Pulmonary Nodules
Objective To explore the therapeutic effect of traditional Chinese medicine(TCM)on subsolid nodule(SSN).Methods A practical randomized controlled study method,including 254 SSN patients was adopted.The patients were divided into the TCM(102 cases)and follow-up(152 cases)groups.The follow-up group received regular check-ups in accordance with the guidelines,and the TCM group received TCM syndrome differentiation treatment for 24 weeks.The two groups were compared in terms of the changes in their SSN diameter,SSN number,TCM symptom score,and overall therapeutic effect before and after treatment.Adverse reactions and safety indicators were also recorded.Results The TCM group showed a significantly higher effective rate of treatment(16.7%)than the follow-up group(2.6%)(P<0.01).Compared with their condition before treatment,the TCM group showed no significant changes in their SSN diameter and number but presented considerably reduced fatigue,yellow and red urine symptoms,and overall TCM symptom score(P<0.05).The follow-up group exhibited significantly increased diameter and number of SSN(P<0.01).The follow-up group showed the significantly higher increase in SSN diameter after treatment than the TCM group(P<0.05).Moreover,the follow-up group showed significantly higher fatigue,depression,yellow and red urine symptom scores,and overall TCM symptom score than the TCM group(P<0.05 or P<0.01).Conclusion TCM treatment for SSN has a distinct clinical efficacy,reduces the malignant risk of SSN and improves clinical symptoms of SSN patients,and is safe and feasible.

Subsolid noduleTCMSyndrome differentiation treatmentPractical randomized controlReal-world study

李玥、胡佳奇、胡越、雷泽杭、王林枫、刘瑞、花宝金

展开 >

100053 北京,中国中医科学院广安门医院肿瘤科

亚实性肺结节 中医药 辨证治疗 实用性随机对照 真实世界研究

国家自然科学基金国家自然科学基金国家中医药局中医药创新团队及人才支持计划中国中医科学院科技创新工程项目中国中医科学院科技创新工程项目国家中医药局岐黄学者支持项目中央高水平中医医院临床研究和成果转化能力提升项目临床科研一体化人才专项青年拔尖人才培育项目

8227460982174465ZYYCXTD-C-202205CI2021A01810CI2021B009HLCMHPP2023101

2024

10.3971/j.issn.1000-8578.2024.23.1110

肿瘤防治研究
湖北省卫生厅,中国抗癌协会,湖北省肿瘤医院

肿瘤防治研究

CSTPCD
影响因子：0.737
ISSN：1000-8578
年,卷(期)：2024.51(5)
  • 8